| Variables . | C-Port® Device (n = 35) . | Control (n = 36) . | P-value . |
|---|---|---|---|
| No. (%) . | No. (%) . | ||
| Prolonged ventilation | 1 (3) | 1 (3) | 1.00 |
| Prolonged inotropics or IABP | 2 (6) | 2 (6) | 1.00 |
| In-hospital mortality | 0 (0) | 0 (0) | N.A. |
| Resternotomy | |||
| Bleeding | 1 (3) | 1 (3) | 1.00 |
| Ischaemia | 0 (0) | 1 (3) | 1.00 |
| Cardiac complications | |||
| Infarction | 2 (6) | 2 (6) | 1.00 |
| Atrial fibrillation | 7 (20) | 6 (17) | 0.76 |
| Pulmonary complications | 4 (11) | 3 (8) | 0.71 |
| Renal complications | 2 (6) | 0 (0 | 0.24 |
| Stroke | 0 (0) | 0 (0) | NA |
| Gastrointestinal complications | 0 (0) | 0 (0) | NA |
| Deep wound infection | 1 (3) | 0 (0) | 0.49 |
| Variables . | C-Port® Device (n = 35) . | Control (n = 36) . | P-value . |
|---|---|---|---|
| No. (%) . | No. (%) . | ||
| Prolonged ventilation | 1 (3) | 1 (3) | 1.00 |
| Prolonged inotropics or IABP | 2 (6) | 2 (6) | 1.00 |
| In-hospital mortality | 0 (0) | 0 (0) | N.A. |
| Resternotomy | |||
| Bleeding | 1 (3) | 1 (3) | 1.00 |
| Ischaemia | 0 (0) | 1 (3) | 1.00 |
| Cardiac complications | |||
| Infarction | 2 (6) | 2 (6) | 1.00 |
| Atrial fibrillation | 7 (20) | 6 (17) | 0.76 |
| Pulmonary complications | 4 (11) | 3 (8) | 0.71 |
| Renal complications | 2 (6) | 0 (0 | 0.24 |
| Stroke | 0 (0) | 0 (0) | NA |
| Gastrointestinal complications | 0 (0) | 0 (0) | NA |
| Deep wound infection | 1 (3) | 0 (0) | 0.49 |
IABP: intra-aortic balloon pump; NA: not applicable.
| Variables . | C-Port® Device (n = 35) . | Control (n = 36) . | P-value . |
|---|---|---|---|
| No. (%) . | No. (%) . | ||
| Prolonged ventilation | 1 (3) | 1 (3) | 1.00 |
| Prolonged inotropics or IABP | 2 (6) | 2 (6) | 1.00 |
| In-hospital mortality | 0 (0) | 0 (0) | N.A. |
| Resternotomy | |||
| Bleeding | 1 (3) | 1 (3) | 1.00 |
| Ischaemia | 0 (0) | 1 (3) | 1.00 |
| Cardiac complications | |||
| Infarction | 2 (6) | 2 (6) | 1.00 |
| Atrial fibrillation | 7 (20) | 6 (17) | 0.76 |
| Pulmonary complications | 4 (11) | 3 (8) | 0.71 |
| Renal complications | 2 (6) | 0 (0 | 0.24 |
| Stroke | 0 (0) | 0 (0) | NA |
| Gastrointestinal complications | 0 (0) | 0 (0) | NA |
| Deep wound infection | 1 (3) | 0 (0) | 0.49 |
| Variables . | C-Port® Device (n = 35) . | Control (n = 36) . | P-value . |
|---|---|---|---|
| No. (%) . | No. (%) . | ||
| Prolonged ventilation | 1 (3) | 1 (3) | 1.00 |
| Prolonged inotropics or IABP | 2 (6) | 2 (6) | 1.00 |
| In-hospital mortality | 0 (0) | 0 (0) | N.A. |
| Resternotomy | |||
| Bleeding | 1 (3) | 1 (3) | 1.00 |
| Ischaemia | 0 (0) | 1 (3) | 1.00 |
| Cardiac complications | |||
| Infarction | 2 (6) | 2 (6) | 1.00 |
| Atrial fibrillation | 7 (20) | 6 (17) | 0.76 |
| Pulmonary complications | 4 (11) | 3 (8) | 0.71 |
| Renal complications | 2 (6) | 0 (0 | 0.24 |
| Stroke | 0 (0) | 0 (0) | NA |
| Gastrointestinal complications | 0 (0) | 0 (0) | NA |
| Deep wound infection | 1 (3) | 0 (0) | 0.49 |
IABP: intra-aortic balloon pump; NA: not applicable.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
